Postremission therapy in adult acute myeloid leukemia (AML): A randomized comparison between high dose ara-C therapy and conventional consolidation therapy (JALSG AML 201 study).

被引：0
|
作者：
Miyawaki, Shuichi [1 ]
Ohtake, Shigeki [1 ]
Fujisawa, Shin [1 ]
Kiyoi, Hitoshi [1 ]
Shinagawa, Katsuji [1 ]
Usui, Noriko [1 ]
Miyamura, Koichi [1 ]
Nishimura, Miki [1 ]
Miyazaki, Yasushi [1 ]
Nishii, Kazuhiro [1 ]
Nagai, Tadashi [1 ]
Yamane, Takahisa [1 ]
Taniwaki, Masafumi [1 ]
Takahashi, Masatomo [1 ]
Yagasaki, Fumiharu [1 ]
Kimura, Yukihiko [1 ]
Asou, Norio [1 ]
Honda, Sumihisa [1 ]
Ohnishi, Kazunori [1 ]
Naoe, Tomoki [1 ]
Ohno, Ryuzo [1 ]
机构：
[1] Saiseikai Maebashi Hosp, Leukaemia Res Ctr, Maebashi, Gumma, Japan
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2005.2005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2005
引用
收藏
页码：567A / 567A
页数：1
相关论文
共 50 条
  • [21] LOW-DOSE ARA-C AS AN ALTERNATIVE THERAPY FOR OLDER PATIENTS WITH AML
    HEYLL, A
    AUL, C
    HEYLL, U
    FISCHER, JT
    SCHNEIDER, W
    BLUT, 1985, 51 (03): : 163 - 163
  • [22] High dose ara-C as upfront therapy for adult patients with acute lymphoblastic leukemia (ALL).
    Hallbook, H
    Simonsson, B
    Bjorkholm, M
    Braide, I
    Carneskog, J
    Grimfors, G
    Hast, R
    Karlsson, R
    Kimby, E
    Lerner, R
    Linder, O
    Linderholm, M
    Lofvenberg, E
    Malm, PG
    Nilsson, PG
    Paul, C
    Petrescu, A
    Rodjer, S
    Tidefelt, U
    Turesson, I
    Uden-Blohme, AM
    Vilen, L
    Winquist, I
    Zettervall, O
    Smedmyr, B
    BLOOD, 1999, 94 (10) : 297A - 297A
  • [23] CYTOSINE-ARABINOSIDE (ARA-C) IN INTERMEDIATE DOSES (IDAC) AS THERAPY FOR PATIENTS (PTS) WITH ACUTE MYELOID-LEUKEMIA (AML)
    ESTEY, EH
    PLUNKETT, WK
    KEATING, MJ
    MCCREDIE, KB
    FREIREICH, EJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 209 - 209
  • [24] Distinct Proteomic Signaling Networks Stratify Responses to Ara-C Based Induction Therapy in Patients with Acute Myeloid Leukemia (AML).
    Minden, Mark
    Rosen, David
    Putta, Santosh
    Cohen, Aileen
    Francis-Lang, Helen
    Covey, Todd
    Woronicz, John
    Soper, David
    Long, Brian
    Cordeiro, James
    Panganiban-Lustan, Lootsie
    Banville, Steve
    Gayko, Urte
    Cesano, Alessandra
    Fantl, Wendy
    BLOOD, 2008, 112 (11) : 885 - 886
  • [25] Results of high-dose cytarabine consolidation and interferon alpha maintenance therapy in acute myeloid leukemia (AML)
    Saikia, TK
    Advani, SH
    Gopal, R
    Nair, CN
    Sawant, VS
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 226 - 226
  • [26] Idarubicin (IDA) and high dose cytosine arabinoside (HD ARA-C) for induction therapy for AML and AML arising from myelodysplasia (MDS/AML).
    Stein, AS
    ODonnell, MR
    Nademanee, A
    Parker, P
    Lee, J
    Molina, A
    Kashyap, A
    Spielberger, R
    Smith, E
    Planas, I
    Snyder, D
    Somlo, G
    Margolin, K
    Niland, J
    Forman, SJ
    BLOOD, 1995, 86 (10) : 2046 - 2046
  • [27] Prospective multicenter study for patients with therapy - Related acute myeloid leukemia (AML) using intensive induction and postremission therapy.
    Wormann, Bernhard Josef
    Schoch, Claudia
    Reichle, Albrecht
    Staib, Peter
    Ludwig, Wolf-Dieter
    Sauerland, Maria Cristina
    Heinecke, Achim
    Berdel, Wolfgang E.
    Hiddemann, Wolfgang
    Buchner, Thomas
    BLOOD, 2006, 108 (11) : 566A - 566A
  • [28] INTENSIVE POST-REMISSION THERAPY IN ADULTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) USING VARIOUS DOSE SCHEDULES OF ARA-C
    MAYER, RJ
    BLUT, 1988, 57 (04): : 177 - 177
  • [29] Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
    Miyawaki, S
    Kobayashi, T
    Tanimoto, M
    Kuriyama, K
    Murakami, H
    Yoshida, M
    Minami, S
    Minato, K
    Tsubaki, K
    Omoto, E
    Oh, H
    Jinnai, I
    Sakamaki, H
    Hiraoka, A
    Kanamura, A
    Takahashi, I
    Saito, K
    Naoe, T
    Yamada, O
    Asou, N
    Kageyama, S
    Emi, N
    Ueda, T
    Tomonaga, M
    Saito, H
    Ueda, R
    Ohno, R
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 70 (01) : 56 - 57
  • [30] A Phase Ib Dose-Finding Study of Oral Panobinostat In Combination with Cytarabine (ara-C) and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia (AML)
    Krauter, Jurgen
    Schlenk, Richard F.
    Schaich, Markus
    Bouscary, Didier
    Dombret, Herve
    Winiger, Ivo J.
    Squier, Margaret
    Bengoudifa, Bourras-Rezki
    Ottmann, Oliver G.
    BLOOD, 2010, 116 (21) : 1356 - 1356
12345